11 Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators
- 1 December 1994
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 7 (4) , 965-1000
- https://doi.org/10.1016/s0950-3536(05)80133-7
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Effects of acute iron loading on contractility and spontaneous beating rate of cultured rat myocardial cellsBasic Research in Cardiology, 1988
- Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxidesFEBS Letters, 1986
- Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agentsBiochemical and Biophysical Research Communications, 1986
- Postischemic tissue injury by iron-mediated free radical lipid peroxidationAnnals of Emergency Medicine, 1985
- Anthracycline glycoside-membrane interactionsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1984
- Ribonucleotide Reductase—a Radical EnzymeScience, 1983
- Malaria — Resurgence, Resistance, and ResearchNew England Journal of Medicine, 1983
- Malaria — Resurgence, Resistance, and ResearchNew England Journal of Medicine, 1983
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977